Mike Alexander, Author at PsyNews.com

Home Authors Posts by Watertime

475 POSTS 0 COMMENTS

PT227- Dr. Anne Wagner – Couples Therapy, MDMA, and MAPS

PT226 – Veronika Gold & Harvey Schwartz from Polaris Insight Center

PT230 – Penny White of NeonMind Biosciences

DMT for Depression: Paving the Way for New Medicine

Changa vs. DMT: What You Need to Know

Is the DMT Experience a Hallucination?

Dr. Carl Hart: Demystifying Drugs

Joe Biden’s Evolution on Drug Policy

1...404142...48 Page 41 of 48

EDITOR PICKS

Momentum Amidst Tumult: The FDA Reshuffle, Approval Timelines, and the Compass-Usona...

Field Notes #1: Psychiatrists, Regulators, Ibogaine, and the Race for Psilocybin...

At the Federal Psychedelic Medicine Summit, the Mood Was Urgent, Practical,...

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

PsyNews.com has a single-sector focus. We are a news platform dedicated to covering the psychedelic industry. This includes companies, startups, venture capital firms, investment banks, pharma, research, etc, anything associated with the new emerging industry and asset class. Many of the chemicals and compounds involved are LSD, psilocybin, DMT, ketamine, MDMA, ecstasy, ibogaine, analogs, derivatives, psychedelic mushrooms, fungi, psilocin, entheogens, empathogens, indocybin, magic truffles (psilocybin sclerotia), etc. They range from classical and standard to new and exotic. PsyNews.com will cover all psychedelic news in the psy industry, including current events, updates, and what’s happening everywhere in the sector in term of developments and investments. We will be tracking companies worth, valuation, ROI, financials, stock, revenue, IPO’s, and more. Along with medical, recreational, clinical trials, FDA, mindfulness, psy space, 5-HT2A receptor experiments, and so forth. Join us on an unforgettable journey to the center of the psychedelic industry.

Watertime

PTSF 43